Literature DB >> 795574

Antibody-mediated immunity in CFW mice infected with Mycobacterium lepraemurium. Humoral immune response in murine leprosy.

O Rojas-Espinosa, M Casoluengo-Méndez, G V Díaz.   

Abstract

A depression in antibody-mediated immunity (AMI) measured both in terms of circulating antibody and plaque-forming cells in the spleen was observed in CFW mice infected with M. lepraemurium when sheep red blood cells (SRBC) and human gammaglobulin (HGG) were used as antigens. The impairment in AMI was evident only after 75 days of infection thereafter the antibody response to SRBC antigen progressively decreased until the last day of experimentation (135 days). Within the first 60 days of infection no alteration in AMI was observed with the HGG antigen while the response to the SRBC antigen was significantly higher in the infected animals than in uninfected controls.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 795574      PMCID: PMC1540956     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

1.  Plaque formation in agar by single antibody-producing cells.

Authors:  N K JERNE; A A NORDIN
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

2.  Notification of leprosy.

Authors:  R G COCHRANE
Journal:  Int J Lepr       Date:  1953 Jul-Sep

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  [Electrophoretic studies in various clinical forms of leprosy].

Authors:  G HOXTER; L BATISTA; L L VELLINI
Journal:  Rev Bras Leprol       Date:  1951-03

5.  Impaired delayed hypersensitivity in patients with lepromatous leprosy.

Authors:  D S Waldorf; J N Sheagren; J R Trautman; J B Block
Journal:  Lancet       Date:  1966-10-08       Impact factor: 79.321

6.  The surface structure of M. leprae.

Authors:  S Sato; M Imi
Journal:  Int J Lepr Other Mycobact Dis       Date:  1968 Jul-Sep

7.  Cell-mediated immunity in patients with leprosy.

Authors:  J L Turk; M F Waters
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

8.  Significance of serologic abnormalities in lepromatous leprosy.

Authors:  A N Malaviya; A Pasricha; J S Pasricha; J S Mehta
Journal:  Int J Lepr Other Mycobact Dis       Date:  1972 Oct-Dec

9.  Hypergammaglobulinemia, secondary macroglobulinemia and paraproteinemia in leprosy.

Authors:  L Bonomo; F Dammacco; U Gillardi
Journal:  Int J Lepr Other Mycobact Dis       Date:  1969 Jul-Sep

10.  Consequences of smallpox vaccination in leprosy patients.

Authors:  K Saha; M M Mittal; S N Ray
Journal:  Infect Immun       Date:  1973-09       Impact factor: 3.441

View more
  3 in total

1.  Suppression of T-cell responses to histocompatibility antigens by BCG pre-treatment.

Authors:  S Orbach-Arbouys; M Castes
Journal:  Immunology       Date:  1980-02       Impact factor: 7.397

2.  Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

3.  Influence of route of Mycobacterium lepraemurium injection on susceptibility to mouse leprosy and on lymphoblastic transformation.

Authors:  R Turcotte
Journal:  Infect Immun       Date:  1980-06       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.